Anabella Villalobos

Director/Board Member at COYA THERAPEUTICS, INC.

Net worth: 58 500 $ as of 2026-06-29

67 year

Health Technology

Consumer Services

Profile

Anabella Villalobos currently works at Coya Therapeutics, Inc., as Independent Director from 2021.
Dr. Villalobos also formerly worked at Biogen, Inc., as SVP-Biotherapeutics & Medicinal Sciences from 2017 to 2025 and Pfizer Inc., as Vice President from 1989 to 2017.
Dr. Villalobos received her doctorate degree from the University of Kansas and undergraduate degree from the University of Panama.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
COYA THERAPEUTICS, INC. 0.04%	2026-04-30	10,000 ( 0.04% )	58 500 $	2026-06-29

Anabella Villalobos active positions

Companies	Position	Start
COYA THERAPEUTICS, INC.	Director/Board Member	2021-05-24

All active positions of Anabella Villalobos

Former positions of Anabella Villalobos

Companies	Position	End
BIOGEN INC.	Corporate Officer/Principal	2024-12-31
PFIZER INC.	Corporate Officer/Principal	2016-12-31

See the detail of Anabella Villalobos's experience

Training of Anabella Villalobos

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Anabella Villalobos's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Pfizer Inc. Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients	Health Technology
Biogen, Inc. Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases	Health Technology
University of Kansas University of Kansas Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Panama University of Panama Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Coya Therapeutics, Inc. Coya Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that focuses on research and development of therapies to enhance the function of regulatory T cells	Health Technology